Theratechnologies Inc. (TSE:TH – Get Free Report) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$1.72 and traded as high as C$1.77. Theratechnologies shares last traded at C$1.73, with a volume of 12,580 shares changing hands.
Theratechnologies Price Performance
The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64. The stock has a market capitalization of C$76.79 million, a price-to-earnings ratio of -9.33, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. The stock has a 50 day moving average price of C$1.72 and a 200-day moving average price of C$1.79.
Theratechnologies (TSE:TH – Get Free Report) last released its earnings results on Thursday, October 10th. The company reported C$0.09 earnings per share (EPS) for the quarter. The business had revenue of C$30.96 million during the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. On average, analysts forecast that Theratechnologies Inc. will post 0.0298643 earnings per share for the current year.
About Theratechnologies
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Further Reading
- Five stocks we like better than Theratechnologies
- Where to Find Earnings Call Transcripts
- How Whitestone REIT is Transforming Sunbelt Retail Growth
- 3 Monster Growth Stocks to Buy Now
- Top-Performing Non-Leveraged ETFs This Year
- Trading Stocks: RSI and Why it’s Useful
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.